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Abstract  Incidence  of  colorectal  cancer  is  known  to  increase  with  age;  however,  the  number
of cases  diagnosed  in  young  patients  is  now  on  the  rise.  Both  histopathology  and  staging  is
thought to  be  more  aggressive  in  the  young.
Objective:  To  determine  whether  age  (<40)  is  a  risk  factor  for  signet  ring  cell,  mucinous,  or
poorly differentiated  adenocarcinoma,  and  for  initial  diagnosis  at  stage  4.
Methods:  We  conducted  a  chart  review  of  patients  admitted  to  our  ward  with  colorectal  cancer
between January  2010  and  December  2013.  We  collected  the  following  variables:  sex,  age,
tumour site,  histopathological  characteristics,  clinical  stage  and  surgery  performed.
Results:  A  total  of  152  patients  were  included,  20  aged  40  years  or  younger,  and  132  aged  over
40 years.  In  the  young  population,  15%  presented  aggressive  tumours  (mucinous  or  signet  ring
cell adenocarcinoma),  and  25%  were  diagnosed  at  stage  4.  Analysis  of  age,  aggressive  tumour,
and stage  4  tumour  variables  between  groups  showed  no  signiﬁcant  differences  (p  >  0.05).
Conclusions:  Young  (<40  years)  age  is  not  a  risk  factor  for  presenting  aggressive  or  stage  4
tumours.
© 2015  Sociedad  Médica  del  Hospital  General  de  México.  Published  by  Masson  Doyma  México
S.A. All  rights  reserved.PALABRAS  CLAVE
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Diferencia  clinicopatológica  del  cáncer  de  colon  y  recto  en  pacientes  menores  y
mayores  de  40  an˜osrecto;
Edad;
Histopatología
Resumen  El  cáncer  de  colon  y  recto  es  una  neoplasia  con  aumento  en  su  incidencia  con  la
edad, sin  embargo  el  diagnostico  en  pacientes  jóvenes  se  ha  incrementado.  La  histopatología
y el  estadio  clínico  se  piensa  que  es  más  agresivo  en  los  jóvenes.∗ Corresponding author at: Dr. Balmis No. 148, Col. Doctores, Delegación Cuauhtémoc, Mexico City C.P. 06726, Mexico.
E-mail address: fatimagjd@gmail.com (F. González Jáuregui-Díaz).
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Objetivo:  Determinar  si  la  edad  menor  de  40  an˜os  es  un  factor  de  riesgo  para  presentar
adenocarcinoma  en  anillo  de  sello,  mucinoso  o  de  baja  diferenciación  y  para  diagnosticarse
inicialmente  en  estadio  IV.
Métodos:  Se  revisaron  los  expedientes  de  pacientes  con  diagnóstico  de  cáncer  de  colon  o  de
recto de  enero  del  2010  a  diciembre  del  2013  que  ingresaron  a  nuestra  Unidad.  Se  recabaron
las siguientes  variables:  sexo,  edad,  localización  del  tumor,  características  histopatológicas,
estadio  clínico  y  cirugía  realizada.
Resultados:  Se  incluyeron  152  pacientes,  20  pacientes  de  40  an˜os  o  menos  y  132  pacientes
mayores de  40  an˜os.  El  15%  de  la  población  joven  presentó  tumores  agresivos  (adenocarcinoma
mucinoso  o  con  células  en  anillo  de  sello)  y  el  25%  se  encontró  en  estadio  clínico  IV  durante
su valoración.  El  análisis  entre  los  2  grupos  de  pacientes  de  acuerdo  a  su  edad  y  las  variables
tumores agresivos  y  estadio  IV  no  fue  signiﬁcativa  (p>0.05).
Conclusiones:  La  edad  menor  de  40  an˜os  no  es  un  factor  de  riesgo  para  presentar  tumores
agresivos  ni  estadio  clínico  IV.
© 2015  Sociedad  Médica  del  Hospital  General  de  México.  Publicado  por  Masson  Doyma  México
S.A. Todos  los  derechos  reservados.
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olorectal  cancer  (CRC)  causes  nearly  608,000  deaths  each
ear.1
Incidence  increases  with  age,  and  over  90%  of  cases
resent  in  patients  aged  over  50  years.  Nevertheless,
he  number  of  cases  in  younger  (aged  40  years  or  less)
atients,  usually  with  more  aggressive  histopathology  and
ore  advanced  tumour  staging,  is  increasing.1
Histology  shows  poorly  differentiated,  mucinous  or  signet
ing  cell  adenocarcinoma.  As  younger  patients  are  diagnosed
t  stage  3  or  4,  treatment  is  usually  either  aggressive  surgical
esection  or  palliative  care,1--4 suggesting  a  worse  prognosis
n  the  younger  patient  population.
In  this  study,  we  analysed  the  records  of  patients  admit-
ed  to  our  ward  to  explore  differences  in  adenocarcinoma
ifferentiation  and  tumour  stage  between  patients  under
nd  over  the  age  of  40  years.
aterials and methods
 total  of  165  patients  admitted  to  our  ward  were  diagnosed
ith  colorectal  cancer  conﬁrmed  by  histopathology  between
anuary  2010  and  December  2013.  Of  these,  13  patients
ere  excluded:  4  due  to  CRC  associated  with  inﬂammatory
owel  disease,  and  9  due  to  lack  of  diagnostic  histopath-
logy  performed  in  our  hospital  or  tumour  staging  study.
f  the  152  remaining  patients,  we  analysed  the  following
ariables:  sex,  age,  tumour  site,  histopathological  differen-
iation,  tumour  stage,  and  surgery  performed.  Parameters
ere  compared  with  those  of  patients  aged  ≤40  years  at  the
ime  of  diagnosis.  The  following  colon  segments  were  ana-
ysed:  the  ascending  (right)  colon  (caecum,  hepatic  ﬂexure),
ight  half  of  the  transverse  colon,  left  half  of  the  trans-
erse  colon,  descending  colon  (sigmoid  colon,  rectosigmoid
unction)  and  rectum.
Aggressive  adenocarcinoma  was  deﬁned  as:  poorly  differ-
ntiated,  mucinous,  or  signet  ring  cell.  According  to  version
A
w
( of  the  TNM,  stage  4  is  distant  metastasis  with  a  higher  risk
or  short-term  mortality.
tatistical  analysis
arameters  obtained  were  entered  into  an  Excel  2010
atabase.  Measures  of  central  tendency  and  scatter  were
alculated  for  quantitative  variables,  and  odds  ratio  plus
onﬁdence  interval  were  calculated  for  qualitative  variables
sing  the  Fisher’s  exact  or  Chi-squared  test,  as  applicable.
igniﬁcance  was  set  at  p  ≤  0.05.  Statistical  analysis  was  per-
ormed  on  SPSS  version  20.
nclusion  criteria
atients  of  legal  age,  admitted  to  our  ward  with  colorectal
ancer,  with  complete  medical  records,  and  with  histopath-
logy  and  imaging  ﬁndings  to  evaluate  tumour  extension.
xclusion  criteria
atients  whose  records  did  not  include  the  study  variables,
nd  tumour  associated  with  inﬂammatory  bowel  disease.
esults
emography total  of  152  patients  were  included  in  the  study.  Mean  age
as  57.9  years;  87  were  men  (57.2%)  and  65  were  women
42.8%);  20  patients  (13.15%)  were  under  40  years  of  age.
Colorectal  cancer  in  patients  under  40  
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Figure  1  Tumour  histopathology.
Tumour  characteristics
Tumours  were  located  in  the  following  segments:  27  (17.8%)
in  the  ascending  colon,  26  (17.1%)  in  the  descending  colon,
and  99  (65.1%)  in  the  rectum.
The  most  common  histopathological  grade  was  mod-
erately  differentiated  adenocarcinoma  (76.3%),  followed
by  well-differentiated  (6.6%),  poorly  differentiated  (7.9%),
mucinous  (7.9%)  and  signet  ring  cell  (1.3%).
Most  patients  presented  at  stage  IIA  (21.7%)  and  IIIB
(20.4%).
The  most  common  surgical  procedures  were  ultralow
anterior  resection  in  19.7%  (UAR)  and  low  anterior  resection
in  18.4%.
Twenty  patients  were  under  40  years  of  age,  and  132  were
over  this  age.
In both  groups,  patients  were  predominantly  male:  55%
(11)  vs.  45%  (9)  in  the  younger  population,  and  57.6%  (76)
vs.  42.4%  (46)  in  the  older  population.
Rectal  tumours  were  more  common  than  those  located
in  the  colon:  65%  (13  vs.  7  patients)  in  the  under-40  group,
and  65.2%  (86  vs.  46  patients)  in  the  over-40  population.
In  terms  of  histopathology,  85%  of  younger  patients  had
good  prognosis  (moderately  and  well-differentiated),  and
15%  had  aggressive  (poorly  differentiated,  mucinous,  or
signet  ring  cell)  tumours.  In  the  over-40  group,  these  varia-
bles  were  91.7%  and  8.3%,  respectively;  the  difference  was
not  statistically  signiﬁcant  (p  =  0.39)  (Fig.  1).  In  the  younger
population,  25%  (3)  presented  with  stage  4  cancer  vs.  15.8%
(17)  in  the  over-40  groups;  the  difference  was  not  statisti-
cally  signiﬁcant  (p  =  0.32)  (Fig.  2).
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Figure  2  Tumour  staging.
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iscussion
here  is  no  consensus  on  the  deﬁnition  of  ‘‘young’’  CRC  can-
er  patients.  In  some  studies,  young  patients  are  under  50
ears,5--7 although  others  set  the  limit  at  30  years.8 Most
uthors,  however,  deﬁne  ‘‘young’’  as  40  years  or  less,  and
his  is  the  deﬁnition  used  in  our  study.1,4,9,10
According  to  the  literature,  CRC  is  more  common  in  the
ver-50  age  group,  and  is  found  in  only  7%  of  patients  aged
40  years.1,4 In  the  USA,  however,  prevalence  among  the
0-  to  40-year  population  increased  to  17%  from  1973  to
999,  a  rate  that  is  similar  to  the  current  prevalence  (13%)
n  Mexico.  A  study  published  by  a  group  from  the  General
ospital  of  Mexico  in  2009  that  included  patient  data  from
he  preceding  20  years  found  a  CRC  prevalence  of  6.4%  in
he  under-40  population.11 An  Argentinian  study  published
y  Irin˜iz  et  al.  reported  a  prevalence  of  17.5%  in  the  under-
0s.12
Most  of  these  studies  found  no  signiﬁcant  difference  in
ender  among  CRC  patients  aged  under  40  years.  In  our
tudy,  57.2%  of  the  total  sample  and  55%  of  the  under-40
opulation  were  men.  In  some  studies,  the  proportion  of
omen  outweighed  that  of  men.11
We  also  analysed  tumour  site  according  to  different  seg-
ents  of  the  colon  and  the  rectum.  Most  studies  report  the
ectum  and  the  sigmoid  colon  as  the  site  of  over  33%  of
umours.11,13,14 In  our  study,  65.1%  of  tumours  were  located
n  the  rectum.  In  our  ward,  this  could  be  due  to  2  fac-
ors:  (1)  colon  tumours  are  managed  in  the  emergency  unit
nd  in  the  general  surgery  and  oncology  wards;  (2)  patients
ith  rectal  tumours  are  usually  referred  to  our  ward  with
astrointestinal  bleeding  due  to  haemorrhoidal  disease.
Histopathological  grading  in  our  population  showed  76.3%
f  patients  with  moderately  differentiated  tumours,  a  ﬁnd-
ng  that  is  consistent  with  most  studies  analysed.11,13,14
mong  the  under-40  population  in  our  study,  15%  presented
ith  mucinous  or  signet  ring  cell  adenocarcinoma,  a  rate
hat  is  below  that  reported  elsewhere  in  the  literature.  Khal-
fa  et  al.14 in  2013,  reported  31%  of  young  patients  with
ucinous  tumours,  and  Ganapathi  et  al.1 in  2011  reported  a
revalence  of  32%.
Survival  rate  in  young  patients  is  considered  to  be  poorer
han  in  the  older  population.  Many  studies15--18 have  reported
ore  advanced  tumour,  and  consequently  worse  prognosis,
n  younger  patients.
We,  however,  found  no  signiﬁcant  differences  between
tudy  groups  with  respect  to  presentation  at  stage  4.  Chou
t  al.4 reported  3  times  as  many  patients  at  this  stage,  with  a
requency  of  82%,  a  signiﬁcant  ﬁnding  when  compared  with
he  older  group  analysed  in  this  study.
onclusion
ounger  age  (40  years  or  less)  is  not  an  independent  risk
actor  for  presenting  a  more  aggressive  tumour  type  or  more
dvanced  stage.onﬂict of interest
he  authors  declare  that  they  have  no  conﬂict  of  interests.
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